<?xml version='1.0' encoding='ASCII'?>
<!--Inline XBRL document created by Certent CDM HD version: 23.4.1 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:vaxx="http://www.vaxxinity.com/20240419" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" version="-//XBRL International//DTD XHTML Inline XBRL 1.1//EN" xml:lang="en-US">
<head><title>8k20240419</title>
<meta http-equiv="Content-Type" content="text/html;"/>
</head>
<body style="background-color:RGB(230, 230, 230);font-family:Times New Roman;font-style:normal;font-size:13.36px;font-weight:normal;font-stretch:normal;color:#000000;">
<div style="display:none;">
<ix:header>
<ix:hidden>
<ix:nonNumeric id="ID_16" name="dei:AmendmentFlag" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">false</ix:nonNumeric>
<ix:nonNumeric id="ID_17" name="dei:EntityCentralIndexKey" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">0001851657</ix:nonNumeric>
<ix:nonNumeric id="ID_22" name="dei:SecurityExchangeName" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">NASDAQ</ix:nonNumeric>
</ix:hidden>
<ix:references xml:lang="en-US"><link:schemaRef xlink:href="vaxx-20240419.xsd" xlink:type="simple"/></ix:references>
<ix:resources>

  <xbrli:context id="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001851657</xbrli:identifier>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startDate>2024-04-19</xbrli:startDate>

      <xbrli:endDate>2024-04-19</xbrli:endDate>

    </xbrli:period>

  </xbrli:context>
</ix:resources>
</ix:header>
</div>
<div id="fixed-layout-inline-document" style="display:none;"></div>
<div id="Doc1" style="background-color:RGB(230, 230, 230);line-height:normal;font-family:Times New Roman;font-size:13.36px;font-weight:400;">
<div style="padding: 7px">
<div id="Page1" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:724.1px; height:2px; left:46px; top:48.1px; background-color:#000000; ">&#160;</div>
<div style="position:absolute; width:724.1px; height:2px; left:46px; top:52.1px; background-color:#000000; ">&#160;</div>
<div style="position:absolute; width:244.8px; height:1.3px; left:48px; top:800.9px; background-color:#000000; ">&#160;</div>
<div style="position:absolute; width:230.4px; height:1.3px; left:300px; top:800.9px; background-color:#000000; ">&#160;</div>
<div style="position:absolute; width:230.4px; height:1.3px; left:537.7px; top:800.9px; background-color:#000000; ">&#160;</div>
<div style="position:absolute; width:724.1px; height:2px; left:46px; top:966px; background-color:#000000; ">&#160;</div>
<div style="position:absolute; width:724.1px; height:2px; left:46px; top:962px; background-color:#000000; ">&#160;</div>
<div id="a1" style="position:absolute;font-family:'Times New Roman';font-size:24px;font-weight:bold;left:312px;top:56px;">UNITED STATES</div><div id="a3" style="position:absolute;font-family:'Times New Roman';font-size:24px;font-weight:bold;left:150px;top:83px;">SECURITIES AND EXCHANGE COMMISSION </div><div id="a6" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:339px;top:126px;">Washington, D.C. 20549 </div><div id="a8" style="position:absolute;font-family:'Times New Roman';left:308px;top:141px;">______________________________ </div><div id="a10" style="position:absolute;font-family:'Times New Roman';font-size:24px;font-weight:bold;left:349px;top:157px;">FORM </div><div id="a10_5_3" style="position:absolute;font-family:'Times New Roman';font-size:24px;font-weight:bold;left:428px;top:157px;"><ix:nonNumeric id="ID_0" name="dei:DocumentType" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">8-K</ix:nonNumeric></div><div id="a14" style="position:absolute;font-family:'Times New Roman';left:288px;top:184px;">____________________________________ </div><div id="a16" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:346px;top:200px;">CURRENT REPORT</div><div id="a18" style="position:absolute;font-family:'Times New Roman';left:406px;top:215px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a20" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:292px;top:230px;">PURSUANT TO SECTION 13 OR 15(d)<div style="display:inline-block;width:3px">&#160;</div></div><div id="a26" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:259px;top:246px;">OF THE SECURITIES EXCHANGE ACT OF 1934</div><div id="a30" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:95px;top:276px;">Date of Report (Date of earliest event reported):</div><div id="a38" style="position:absolute;font-family:'Times New Roman';font-size:1.36px;font-weight:bold;left:415px;top:290px;"><div style="display:inline-block;width:1px">&#160;</div></div><div id="a40" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:569px;top:276px;"><ix:nonNumeric id="ID_1" name="dei:DocumentPeriodEndDate" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657" format="ixt:datemonthdayyearen">April 19, 2024</ix:nonNumeric></div><div id="a42" style="position:absolute;font-family:'Times New Roman';left:288px;top:292px;">____________________________________ </div><div id="a44" style="position:absolute;font-family:'Times New Roman';left:48px;top:307px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a46" style="position:absolute;font-family:'Times New Roman';font-size:24px;font-weight:bold;left:332px;top:323px;"><ix:nonNumeric id="ID_2" name="dei:EntityRegistrantName" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">Vaxxinity, Inc.</ix:nonNumeric></div><div id="a48" style="position:absolute;font-family:'Times New Roman';left:270px;top:350px;">(Exact name of registrant as specified in its charter) </div><div id="a50" style="position:absolute;font-family:'Times New Roman';left:288px;top:365px;">____________________________________ </div><div id="a52" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:49px;top:381px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a54" style="position:absolute;font-family:'Times New Roman';left:289px;top:381px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a56" style="position:absolute;font-family:'Times New Roman';left:764px;top:381px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a58" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:141px;top:396px;"><ix:nonNumeric id="ID_3" name="dei:EntityIncorporationStateCountryCode" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></div><div id="a60" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:379px;top:396px;"><ix:nonNumeric id="ID_4" name="dei:EntityFileNumber" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">001-41058</ix:nonNumeric></div><div id="a64" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:616px;top:396px;"><ix:nonNumeric id="ID_5" name="dei:EntityTaxIdentificationNumber" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">86-2083865</ix:nonNumeric></div><div id="a68" style="position:absolute;font-family:'Times New Roman';left:98px;top:411px;">(State or other jurisdiction </div><div id="a70" style="position:absolute;font-family:'Times New Roman';left:372px;top:411px;">(Commission </div><div id="a72" style="position:absolute;font-family:'Times New Roman';left:607px;top:411px;">(IRS Employer </div><div id="a74" style="position:absolute;font-family:'Times New Roman';left:123px;top:427px;">of incorporation) </div><div id="a76" style="position:absolute;font-family:'Times New Roman';left:372px;top:427px;">File Number) </div><div id="a78" style="position:absolute;font-family:'Times New Roman';left:598px;top:427px;">Identification No.) </div><div id="a80" style="position:absolute;font-family:'Times New Roman';left:49px;top:442px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a82" style="position:absolute;font-family:'Times New Roman';left:289px;top:442px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a84" style="position:absolute;font-family:'Times New Roman';left:764px;top:442px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a89" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:358px;top:473px;"><ix:nonNumeric id="ID_18" name="dei:EntityAddressAddressLine1" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">505 Odyssey Way</ix:nonNumeric></div><div id="a91" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:337px;top:488px;"><ix:nonNumeric id="ID_19" name="dei:EntityAddressCityOrTown" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">Merritt Island</ix:nonNumeric></div><div id="a91_14_2" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:419px;top:488px;">, </div><div id="a91_16_2" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:425px;top:488px;"><ix:nonNumeric id="ID_20" name="dei:EntityAddressStateOrProvince" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">FL</ix:nonNumeric></div><div id="a91_19_5" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:446px;top:488px;"><ix:nonNumeric id="ID_21" name="dei:EntityAddressPostalZipCode" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">32953</ix:nonNumeric></div><div id="a93" style="position:absolute;font-family:'Times New Roman';left:271px;top:503px;">(Address of principal executive offices) (Zip Code) </div><div id="a97" style="position:absolute;font-family:'Times New Roman';left:49px;top:519px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a99" style="position:absolute;font-family:'Times New Roman';left:316px;top:519px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a101" style="position:absolute;font-family:'Times New Roman';left:764px;top:519px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a103" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:215px;top:534px;">Registrant&#8217;s telephone number,<div style="display:inline-block;width:5px">&#160;</div>including area code: (</div><div id="a103_53_3" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:522px;top:534px;"><ix:nonNumeric id="ID_6" name="dei:CityAreaCode" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">254</ix:nonNumeric></div><div id="a103_56_2" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:542px;top:534px;">) </div><div id="a103_58_8" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:549px;top:534px;"><ix:nonNumeric id="ID_7" name="dei:LocalPhoneNumber" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">244-5739</ix:nonNumeric></div><div id="a108" style="position:absolute;font-family:'Times New Roman';left:48px;top:549px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a110" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:365px;top:565px;">Not Applicable</div><div id="a112" style="position:absolute;font-family:'Times New Roman';left:244px;top:580px;">(Former name or former address, if changed since last report) </div><div id="a116" style="position:absolute;font-family:'Times New Roman';left:288px;top:595px;">____________________________________ </div><div id="a118" style="position:absolute;font-family:'Times New Roman';left:48px;top:611px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a120" style="position:absolute;font-family:'Times New Roman';left:48px;top:626px;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant </div><div id="a123" style="position:absolute;font-family:'Times New Roman';left:48px;top:641px;">under any of the following provisions: </div><div id="a125" style="position:absolute;font-family:'Times New Roman';left:48px;top:657px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a127" style="position:absolute;font-family:'Segoe UI Symbol';left:48px;top:672px;"><ix:nonNumeric id="ID_8" name="dei:WrittenCommunications" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div><div id="a128" style="position:absolute;font-family:'Times New Roman';left:60px;top:674px;"><div style="display:inline-block;width:7px">&#160;</div>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </div><div id="a131" style="position:absolute;font-family:'Segoe UI Symbol';left:48px;top:689px;"><ix:nonNumeric id="ID_9" name="dei:SolicitingMaterial" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div><div id="a132" style="position:absolute;font-family:'Times New Roman';left:60px;top:692px;"><div style="display:inline-block;width:7px">&#160;</div>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </div><div id="a139" style="position:absolute;font-family:'Segoe UI Symbol';left:48px;top:707px;"><ix:nonNumeric id="ID_10" name="dei:PreCommencementTenderOffer" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div><div id="a140" style="position:absolute;font-family:'Times New Roman';left:60px;top:709px;"><div style="display:inline-block;width:7px">&#160;</div>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </div><div id="a149" style="position:absolute;font-family:'Segoe UI Symbol';left:48px;top:725px;"><ix:nonNumeric id="ID_11" name="dei:PreCommencementIssuerTenderOffer" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div><div id="a150" style="position:absolute;font-family:'Times New Roman';left:60px;top:727px;"><div style="display:inline-block;width:7px">&#160;</div>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </div><div id="a159" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:48px;top:743px;"><div style="display:inline-block;width:3px">&#160;</div></div><div id="a161" style="position:absolute;font-family:'Times New Roman';left:48px;top:758px;">Securities registered pursuant to Section 12(b) of the Act: </div><div id="a165" style="position:absolute;font-family:'Times New Roman';font-size:10.64px;font-weight:bold;left:130px;top:787px;">Title of each class </div><div id="a168" style="position:absolute;font-family:'Times New Roman';font-size:10.64px;font-weight:bold;left:397px;top:775px;">Trading </div><div id="a170" style="position:absolute;font-family:'Times New Roman';font-size:10.64px;font-weight:bold;left:392px;top:787px;">Symbol(s) </div><div id="a173" style="position:absolute;font-family:'Times New Roman';font-size:10.64px;font-weight:bold;left:600px;top:775px;">Name of each exchange </div><div id="a175" style="position:absolute;font-family:'Times New Roman';font-size:10.64px;font-weight:bold;left:608px;top:787px;">on which registered </div><div id="a177" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:50px;top:802px;"><ix:nonNumeric id="ID_13" name="dei:Security12bTitle" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657" continuedAt="XBRL_CS_554ec84c04af4e189c964f216a94b90c_1">Class A Common Stock, par value $0.0001 </ix:nonNumeric></div><div id="a183" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:144px;top:818px;"><ix:continuation id="XBRL_CS_554ec84c04af4e189c964f216a94b90c_1">per share</ix:continuation></div><div id="a187" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:396px;top:802px;"><ix:nonNumeric id="ID_14" name="dei:TradingSymbol" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657">VAXX</ix:nonNumeric></div><div id="a190" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:574px;top:802px;">The </div><div id="a190_4_6" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:600px;top:802px;-sec-ix-hidden:ID_22;">Nasdaq</div><div id="a190_10_16" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:643px;top:802px;"><div style="display:inline-block;width:3px">&#160;</div>Global Market<div style="display:inline-block;width:3px">&#160;</div></div><div id="a195" style="position:absolute;font-family:'Times New Roman';left:48px;top:849px;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 </div><div id="a197" style="position:absolute;font-family:'Times New Roman';left:48px;top:864px;">(&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </div><div id="a206" style="position:absolute;font-family:'Times New Roman';left:48px;top:897px;">Emerging growth company<div style="display:inline-block;width:7px">&#160;</div></div><div id="a208" style="position:absolute;font-family:'Segoe UI Symbol';left:201px;top:895px;"><ix:nonNumeric id="ID_15" name="dei:EntityEmergingGrowthCompany" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></div><div id="a211" style="position:absolute;font-family:'Times New Roman';left:48px;top:928px;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for </div><div id="a214" style="position:absolute;font-family:'Times New Roman';left:48px;top:945px;">complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.<div style="display:inline-block;width:6px">&#160;</div></div><div id="a216" style="position:absolute;font-family:'Segoe UI Symbol';left:713px;top:943px;"><ix:nonNumeric id="ID_12" name="dei:EntityExTransitionPeriod" contextRef="FROM_Apr19_2024_TO_Apr19_2024_Entity_0001851657" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page2" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:110.7px; height:1px; left:45.6px; top:452.2px; background-color:#000000; ">&#160;</div>
<div style="position:absolute; width:534.6px; height:15.4px; left:233.5px; top:638.7px; background-color:#FFFFFF; ">&#160;</div>
<div style="position:absolute; width:372.4px; height:15.3px; left:48px; top:654.1px; background-color:#FFFFFF; ">&#160;</div>
<div id="a219" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:48px;top:48px;">Item 3.01.<div style="display:inline-block;width:39px">&#160;</div>Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. </div><div id="a223" style="position:absolute;font-family:'Times New Roman';left:72px;top:80px;">On April 19, 2024, Vaxxinity,<div style="display:inline-block;width:7px">&#160;</div>Inc. (the &#8220;Company&#8221; or &#8220;Vaxxinity&#8221;<div style="display:inline-block;width:2px">&#160;</div>)<div style="display:inline-block;width:4px">&#160;</div>delivered formal notice to The Nasdaq<div style="display:inline-block;width:5px">&#160;</div>Stock Market LLC of </div><div id="a238" style="position:absolute;font-family:'Times New Roman';left:48px;top:95px;">its intention<div style="display:inline-block;width:6px">&#160;</div>to voluntarily<div style="display:inline-block;width:5px">&#160;</div>delist its<div style="display:inline-block;width:6px">&#160;</div>Class A<div style="display:inline-block;width:6px">&#160;</div>Common Stock,<div style="display:inline-block;width:6px">&#160;</div>par value<div style="display:inline-block;width:6px">&#160;</div>$0.0001 per<div style="display:inline-block;width:6px">&#160;</div>share (the<div style="display:inline-block;width:6px">&#160;</div>&#8220;Common Stock&#8221;),<div style="display:inline-block;width:5px">&#160;</div>from the<div style="display:inline-block;width:6px">&#160;</div>Nasdaq </div><div id="a248" style="position:absolute;font-family:'Times New Roman';left:48px;top:110px;">Global Market ( &#8220;Nasdaq&#8221;) and deregister<div style="display:inline-block;width:2px">&#160;</div>the Common Stock under Section 12(b)<div style="display:inline-block;width:2px">&#160;</div>and Section 12(g) of Securities and<div style="display:inline-block;width:2px">&#160;</div>Exchange Act of </div><div id="a254" style="position:absolute;font-family:'Times New Roman';left:48px;top:126px;">1934, as amended (the &#8220;Exchange Act&#8221;), and suspend its reporting obligations under Section 15(d) of the Exchange Act.<div style="display:inline-block;width:2px">&#160;</div></div><div id="a256" style="position:absolute;font-family:'Times New Roman';left:72px;top:157px;">The<div style="display:inline-block;width:5px">&#160;</div>Company<div style="display:inline-block;width:5px">&#160;</div>intends<div style="display:inline-block;width:5px">&#160;</div>to<div style="display:inline-block;width:5px">&#160;</div>file<div style="display:inline-block;width:5px">&#160;</div>a<div style="display:inline-block;width:5px">&#160;</div>Notification<div style="display:inline-block;width:5px">&#160;</div>of<div style="display:inline-block;width:5px">&#160;</div>Removal<div style="display:inline-block;width:5px">&#160;</div>from<div style="display:inline-block;width:5px">&#160;</div>Listing<div style="display:inline-block;width:5px">&#160;</div>and/or<div style="display:inline-block;width:5px">&#160;</div>Registration<div style="display:inline-block;width:5px">&#160;</div>on<div style="display:inline-block;width:5px">&#160;</div>Form<div style="display:inline-block;width:5px">&#160;</div>25<div style="display:inline-block;width:5px">&#160;</div>with<div style="display:inline-block;width:5px">&#160;</div>the<div style="display:inline-block;width:5px">&#160;</div>Securities<div style="display:inline-block;width:5px">&#160;</div>and </div><div id="a259" style="position:absolute;font-family:'Times New Roman';left:48px;top:172px;">Exchange Commission (the<div style="display:inline-block;width:5px">&#160;</div>&#8220;SEC&#8221;) on or<div style="display:inline-block;width:5px">&#160;</div>about April 29,<div style="display:inline-block;width:5px">&#160;</div>2024 to effect<div style="display:inline-block;width:5px">&#160;</div>the voluntary withdrawal<div style="display:inline-block;width:5px">&#160;</div>of the listing<div style="display:inline-block;width:5px">&#160;</div>of its securities<div style="display:inline-block;width:5px">&#160;</div>from </div><div id="a271" style="position:absolute;font-family:'Times New Roman';left:48px;top:188px;">Nasdaq and the<div style="display:inline-block;width:2px">&#160;</div>deregistration of its<div style="display:inline-block;width:2px">&#160;</div>securities under Section<div style="display:inline-block;width:2px">&#160;</div>12(b) of the<div style="display:inline-block;width:2px">&#160;</div>Exchange Act. The<div style="display:inline-block;width:2px">&#160;</div>Company anticipates that<div style="display:inline-block;width:2px">&#160;</div>the delisting from </div><div id="a275" style="position:absolute;font-family:'Times New Roman';left:48px;top:203px;">Nasdaq<div style="display:inline-block;width:6px">&#160;</div>and<div style="display:inline-block;width:6px">&#160;</div>deregistration<div style="display:inline-block;width:6px">&#160;</div>under<div style="display:inline-block;width:6px">&#160;</div>Section<div style="display:inline-block;width:6px">&#160;</div>12(b)<div style="display:inline-block;width:6px">&#160;</div>of<div style="display:inline-block;width:6px">&#160;</div>its<div style="display:inline-block;width:6px">&#160;</div>securities<div style="display:inline-block;width:6px">&#160;</div>will<div style="display:inline-block;width:6px">&#160;</div>become<div style="display:inline-block;width:6px">&#160;</div>effective<div style="display:inline-block;width:6px">&#160;</div>on<div style="display:inline-block;width:6px">&#160;</div>or<div style="display:inline-block;width:6px">&#160;</div>about<div style="display:inline-block;width:6px">&#160;</div>May<div style="display:inline-block;width:6px">&#160;</div>9,<div style="display:inline-block;width:6px">&#160;</div>2024.<div style="display:inline-block;width:6px">&#160;</div>Following<div style="display:inline-block;width:6px">&#160;</div>the </div><div id="a282" style="position:absolute;font-family:'Times New Roman';left:48px;top:218px;">effectiveness of the Form 25, the Company<div style="display:inline-block;width:2px">&#160;</div>intends to file with the SEC<div style="display:inline-block;width:2px">&#160;</div>a Form 15 to deregister the<div style="display:inline-block;width:2px">&#160;</div>Company&#8217;s securities under Section </div><div id="a284" style="position:absolute;font-family:'Times New Roman';left:48px;top:234px;">12(g) of the Exchange Act, thereby suspending its reporting obligations under the Exchange Act. </div><div id="a291" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:48px;top:265px;">Item 8.01.<div style="display:inline-block;width:39px">&#160;</div>Other Events. </div><div id="a295" style="position:absolute;font-family:'Times New Roman';left:72px;top:296px;">On April<div style="display:inline-block;width:5px">&#160;</div>19, 2024,<div style="display:inline-block;width:5px">&#160;</div>the Company<div style="display:inline-block;width:5px">&#160;</div>issued a<div style="display:inline-block;width:5px">&#160;</div>press release<div style="display:inline-block;width:5px">&#160;</div>announcing its<div style="display:inline-block;width:5px">&#160;</div>intention to<div style="display:inline-block;width:5px">&#160;</div>voluntarily delist<div style="display:inline-block;width:5px">&#160;</div>and deregister<div style="display:inline-block;width:5px">&#160;</div>its Common </div><div id="a305" style="position:absolute;font-family:'Times New Roman';left:48px;top:312px;">Stock. The foregoing description of the press release<div style="display:inline-block;width:5px">&#160;</div>is qualified in its entirety by the full<div style="display:inline-block;width:5px">&#160;</div>text of the press release furnished as Exhibit </div><div id="a310" style="position:absolute;font-family:'Times New Roman';left:48px;top:327px;">99.1 to this Current Report on Form 8-K and incorporated herein by reference. </div><div id="a314" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:48px;top:358px;">Item 9.01.<div style="display:inline-block;width:39px">&#160;</div>Financial Statements and Exhibits. </div><div id="a318" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:48px;top:390px;">(d)<div style="display:inline-block;width:32px">&#160;</div>Exhibits. </div><div id="a322" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:82px;top:421px;">Exhibit </div><div id="a324" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:94px;top:436px;">No.</div><div id="a326" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:430px;top:436px;">Description</div><div id="a328" style="position:absolute;font-family:'Times New Roman';left:48px;top:454px;">99.1 </div><div id="a330" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:159px;top:454px;"><a href="exhibit991.htm" style="color:#0000FF;text-decoration:underline;">Press Release, dated April 19, 2024.</a></div><div id="a332" style="position:absolute;font-family:'Times New Roman';left:48px;top:469px;">104 </div><div id="a334" style="position:absolute;font-family:'Times New Roman';left:159px;top:469px;">Cover Page Interactive Data File (embedded within the Inline XBRL document). </div><div id="a337" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:48px;top:516px;">Forward-Looking Statements </div><div id="a341" style="position:absolute;font-family:'Times New Roman';left:72px;top:547px;">The information contained herein includes forward-looking<div style="display:inline-block;width:5px">&#160;</div>statements, as defined in the<div style="display:inline-block;width:5px">&#160;</div>Private Securities Litigation Reform Act </div><div id="a344" style="position:absolute;font-family:'Times New Roman';left:48px;top:562px;">of 1995. The use<div style="display:inline-block;width:5px">&#160;</div>of certain words, including<div style="display:inline-block;width:5px">&#160;</div>&#8220;believe,&#8221; &#8220;may,&#8221;<div style="display:inline-block;width:5px">&#160;</div>&#8220;continue,&#8221; &#8220;intend,&#8221; &#8220;will,&#8221; &#8220;anticipate,&#8221;<div style="display:inline-block;width:5px">&#160;</div>and similar expressions, are </div><div id="a366" style="position:absolute;font-family:'Times New Roman';left:48px;top:578px;">intended to identify<div style="display:inline-block;width:2px">&#160;</div>forward-looking statements. Forward-looking<div style="display:inline-block;width:1px">&#160;</div>statements include statements,<div style="display:inline-block;width:1px">&#160;</div>other than statements<div style="display:inline-block;width:2px">&#160;</div>of historical fact, </div><div id="a371" style="position:absolute;font-family:'Times New Roman';left:48px;top:593px;">regarding,<div style="display:inline-block;width:5px">&#160;</div>among<div style="display:inline-block;width:5px">&#160;</div>other<div style="display:inline-block;width:5px">&#160;</div>things,<div style="display:inline-block;width:5px">&#160;</div>statements regarding<div style="display:inline-block;width:6px">&#160;</div>the<div style="display:inline-block;width:5px">&#160;</div>Company&#8217;s<div style="display:inline-block;width:5px">&#160;</div>plans<div style="display:inline-block;width:5px">&#160;</div>and<div style="display:inline-block;width:5px">&#160;</div>its<div style="display:inline-block;width:5px">&#160;</div>ability<div style="display:inline-block;width:5px">&#160;</div>to<div style="display:inline-block;width:5px">&#160;</div>successfully delist<div style="display:inline-block;width:6px">&#160;</div>from<div style="display:inline-block;width:5px">&#160;</div>Nasdaq<div style="display:inline-block;width:5px">&#160;</div>and<div style="display:inline-block;width:5px">&#160;</div>to </div><div id="a377" style="position:absolute;font-family:'Times New Roman';left:48px;top:608px;">deregister the Common Stock. These forward-looking statements involve substantial risks and uncertainties.<div style="display:inline-block;width:4px">&#160;</div>Various<div style="display:inline-block;width:5px">&#160;</div>important factors </div><div id="a385" style="position:absolute;font-family:'Times New Roman';left:48px;top:624px;">could cause actual results or events<div style="display:inline-block;width:2px">&#160;</div>to differ materially from those that<div style="display:inline-block;width:2px">&#160;</div>may be expressed or implied by<div style="display:inline-block;width:2px">&#160;</div>our forward-looking statements, </div><div id="a389" style="position:absolute;font-family:'Times New Roman';left:48px;top:639px;">including, but not limited<div style="display:inline-block;width:5px">&#160;</div>to, the timing of<div style="display:inline-block;width:5px">&#160;</div>the effectiveness of the<div style="display:inline-block;width:5px">&#160;</div>Company&#8217;s delisting and<div style="display:inline-block;width:5px">&#160;</div>ability and timing of<div style="display:inline-block;width:5px">&#160;</div>deregistration of the </div><div id="a392" style="position:absolute;font-family:'Times New Roman';left:48px;top:654px;">Common Stock, the Company&#8217;s ability to continue as<div style="display:inline-block;width:2px">&#160;</div>a going concern and those other<div style="display:inline-block;width:2px">&#160;</div>factors described in the &#8220;Risk<div style="display:inline-block;width:2px">&#160;</div>Factors&#8221; section of </div><div id="a401" style="position:absolute;font-family:'Times New Roman';left:48px;top:670px;">Vaxxinity&#8217;s<div style="display:inline-block;width:8px">&#160;</div>Annual<div style="display:inline-block;width:6px">&#160;</div>Report<div style="display:inline-block;width:6px">&#160;</div>on<div style="display:inline-block;width:6px">&#160;</div>Form<div style="display:inline-block;width:6px">&#160;</div>10-K<div style="display:inline-block;width:6px">&#160;</div>for<div style="display:inline-block;width:6px">&#160;</div>the<div style="display:inline-block;width:6px">&#160;</div>year<div style="display:inline-block;width:6px">&#160;</div>ended<div style="display:inline-block;width:6px">&#160;</div>December<div style="display:inline-block;width:6px">&#160;</div>31,<div style="display:inline-block;width:6px">&#160;</div>2023,<div style="display:inline-block;width:6px">&#160;</div>filed<div style="display:inline-block;width:6px">&#160;</div>with<div style="display:inline-block;width:6px">&#160;</div>the<div style="display:inline-block;width:6px">&#160;</div>U.S.<div style="display:inline-block;width:6px">&#160;</div>Securities<div style="display:inline-block;width:6px">&#160;</div>and<div style="display:inline-block;width:6px">&#160;</div>Exchange </div><div id="a408" style="position:absolute;font-family:'Times New Roman';left:48px;top:685px;">Commission<div style="display:inline-block;width:5px">&#160;</div>on<div style="display:inline-block;width:5px">&#160;</div>March<div style="display:inline-block;width:5px">&#160;</div>27,<div style="display:inline-block;width:5px">&#160;</div>2024.<div style="display:inline-block;width:5px">&#160;</div>The<div style="display:inline-block;width:5px">&#160;</div>forward-looking<div style="display:inline-block;width:5px">&#160;</div>statements<div style="display:inline-block;width:5px">&#160;</div>are<div style="display:inline-block;width:5px">&#160;</div>made<div style="display:inline-block;width:5px">&#160;</div>as<div style="display:inline-block;width:5px">&#160;</div>of<div style="display:inline-block;width:5px">&#160;</div>this<div style="display:inline-block;width:5px">&#160;</div>date<div style="display:inline-block;width:5px">&#160;</div>and<div style="display:inline-block;width:5px">&#160;</div>Vaxxinity<div style="display:inline-block;width:7px">&#160;</div>does<div style="display:inline-block;width:5px">&#160;</div>not<div style="display:inline-block;width:5px">&#160;</div>undertake<div style="display:inline-block;width:5px">&#160;</div>any </div><div id="a412" style="position:absolute;font-family:'Times New Roman';left:48px;top:700px;">obligation<div style="display:inline-block;width:5px">&#160;</div>to<div style="display:inline-block;width:5px">&#160;</div>update<div style="display:inline-block;width:5px">&#160;</div>any<div style="display:inline-block;width:5px">&#160;</div>forward-looking<div style="display:inline-block;width:5px">&#160;</div>statements, whether<div style="display:inline-block;width:6px">&#160;</div>as<div style="display:inline-block;width:5px">&#160;</div>a<div style="display:inline-block;width:5px">&#160;</div>result of<div style="display:inline-block;width:6px">&#160;</div>new<div style="display:inline-block;width:5px">&#160;</div>information, future<div style="display:inline-block;width:6px">&#160;</div>events<div style="display:inline-block;width:5px">&#160;</div>or<div style="display:inline-block;width:5px">&#160;</div>otherwise,<div style="display:inline-block;width:5px">&#160;</div>except as </div><div id="a415" style="position:absolute;font-family:'Times New Roman';left:48px;top:716px;">required by law. </div><div id="a417" style="position:absolute;font-family:'Times New Roman';left:48px;top:747px;"><div style="display:inline-block;width:192px">&#160;</div></div></div>
</div>
<div style="padding: 7px">
<div id="Page3" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:724.1px; height:107.4px; left:46px; top:48px; background-color:#FFFFFF; ">&#160;</div>
<div style="position:absolute; width:259.8px; height:1px; left:507.9px; top:217.6px; background-color:#000000; ">&#160;</div>
<div id="a420" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:365px;top:48px;">SIGNATURES </div><div id="a423" style="position:absolute;font-family:'Times New Roman';left:48px;top:79px;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its </div><div id="a425" style="position:absolute;font-family:'Times New Roman';left:48px;top:94px;">behalf by the undersigned hereunto duly authorized. </div><div id="a431" style="position:absolute;font-family:'Times New Roman';left:48px;top:125px;">Date: April 19, 2024 </div><div id="a435" style="position:absolute;font-family:'Times New Roman';left:466px;top:156px;">VAXXINITY,<div style="display:inline-block;width:7px">&#160;</div>INC. </div><div id="a437" style="position:absolute;font-family:'Times New Roman';left:466px;top:203px;">By: </div><div id="a439" style="position:absolute;font-family:'Times New Roman';left:508px;top:203px;">/s/ Mei Mei Hu </div><div id="a443" style="position:absolute;font-family:'Times New Roman';left:508px;top:219px;">Name:<div style="display:inline-block;width:12px">&#160;</div>Mei Mei Hu </div><div id="a448" style="position:absolute;font-family:'Times New Roman';left:508px;top:234px;">Title:<div style="display:inline-block;width:20px">&#160;</div>Chief Executive Officer </div></div>
</div>
</div>
</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "8k20240419.htm", "description": "8-K", "secsgml_size_bytes": 39479}]
{"company-data": {"conformed-name": "Vaxxinity, Inc.", "cik": "0001851657", "assigned-sic": "2834", "organization-name": "03 Life Sciences", "irs-number": "862083865", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-41058", "film-number": "24857795"}, "business-address": {"street1": "505 ODYSSEY WAY", "city": "EXPLORATION PARK", "state": "FL", "zip": "32953", "phone": "(254) 244-5739"}, "mail-address": {"street1": "505 ODYSSEY WAY", "city": "EXPLORATION PARK", "state": "FL", "zip": "32953"}}
8k20240419
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________
FORM
8-K
____________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
April 19, 2024
____________________________________
Vaxxinity, Inc.
(Exact name of registrant as specified in its charter)
____________________________________
Delaware
001-41058
86-2083865
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)
505 Odyssey Way
Merritt Island
,
FL
32953
(Address of principal executive offices) (Zip Code)
Registrant's telephone number,
including area code: (
254
)
244-5739
Not Applicable
(Former name or former address, if changed since last report)
____________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Class A Common Stock, par value $0.0001
per share
VAXX
The
Nasdaq
Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 3.01.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On April 19, 2024, Vaxxinity,
Inc. (the "Company" or "Vaxxinity"
)
delivered formal notice to The Nasdaq
Stock Market LLC of
its intention
to voluntarily
delist its
Class A
Common Stock,
par value
$0.0001 per
share (the
"Common Stock"),
from the
Nasdaq
Global Market ( "Nasdaq") and deregister
the Common Stock under Section 12(b)
and Section 12(g) of Securities and
Exchange Act of
1934, as amended (the "Exchange Act"), and suspend its reporting obligations under Section 15(d) of the Exchange Act.
The
Company
intends
to
file
a
Notification
of
Removal
from
Listing
and/or
Registration
on
Form
25
with
the
Securities
and
Exchange Commission (the
"SEC") on or
about April 29,
2024 to effect
the voluntary withdrawal
of the listing
of its securities
from
Nasdaq and the
deregistration of its
securities under Section
12(b) of the
Exchange Act. The
Company anticipates that
the delisting from
Nasdaq
and
deregistration
under
Section
12(b)
of
its
securities
will
become
effective
on
or
about
May
9,
2024.
Following
the
effectiveness of the Form 25, the Company
intends to file with the SEC
a Form 15 to deregister the
Company's securities under Section
12(g) of the Exchange Act, thereby suspending its reporting obligations under the Exchange Act.
Item 8.01.
Other Events.
On April
19, 2024,
the Company
issued a
press release
announcing its
intention to
voluntarily delist
and deregister
its Common
Stock. The foregoing description of the press release
is qualified in its entirety by the full
text of the press release furnished as Exhibit
99.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits.
Exhibit
No.
Description
99.1
Press Release, dated April 19, 2024.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
Forward-Looking Statements
The information contained herein includes forward-looking
statements, as defined in the
Private Securities Litigation Reform Act
of 1995. The use
of certain words, including
"believe," "may,"
"continue," "intend," "will," "anticipate,"
and similar expressions, are
intended to identify
forward-looking statements. Forward-looking
statements include statements,
other than statements
of historical fact,
regarding,
among
other
things,
statements regarding
the
Company's
plans
and
its
ability
to
successfully delist
from
Nasdaq
and
to
deregister the Common Stock. These forward-looking statements involve substantial risks and uncertainties.
Various
important factors
could cause actual results or events
to differ materially from those that
may be expressed or implied by
our forward-looking statements,
including, but not limited
to, the timing of
the effectiveness of the
Company's delisting and
ability and timing of
deregistration of the
Common Stock, the Company's ability to continue as
a going concern and those other
factors described in the "Risk
Factors" section of
Vaxxinity's
Annual
Report
on
Form
10-K
for
the
year
ended
December
31,
2023,
filed
with
the
U.S.
Securities
and
Exchange
Commission
on
March
27,
2024.
The
forward-looking
statements
are
made
as
of
this
date
and
Vaxxinity
does
not
undertake
any
obligation
to
update
any
forward-looking
statements, whether
as
a
result of
new
information, future
events
or
otherwise,
except as
required by law.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
Date: April 19, 2024
VAXXINITY,
INC.
By:
/s/ Mei Mei Hu
Name:
Mei Mei Hu
Title:
Chief Executive Officer